Cabergoline, a long-acting dopamine agonist, attenuates L-dopa-induced dyskinesia without L-dopa sparing in a rat model of Parkinson's disease.
Neurosci Res
; 178: 93-97, 2022 May.
Article
in En
| MEDLINE
| ID: mdl-35150767
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Parkinson Disease
/
Dyskinesia, Drug-Induced
Limits:
Animals
Language:
En
Journal:
Neurosci Res
Journal subject:
NEUROLOGIA
Year:
2022
Document type:
Article